Moderna Begins Phase 1 Trial for Experimental Ebola Vaccine
Moderna has commenced its first Phase 1 trial for an experimental mRNA Ebola vaccine, authorized by Health Canada, in response to a significant outbreak in Congo.
The Story
Analyzing sources…
Source Diversity
Source Diversity
High (60/100)Sources
Moderna Starts Phase 1 Trial of Experimental Ebola Vaccine for Congo Outbreak
Moderna Inc. has begun testing an experimental Ebola vaccine in people, marking the second candidate to enter clinical trials against the strain driving the deadliest Ebola outbreak in Democratic Republic of Congo’s history.
By Jason Gale
Read full article →Health Canada authorizes mRNA vaccine trial for Ebola virus causing huge outbreak in Congo
<img src='https://i.cbc.ca/ais/f8ec74e7-865d-4cb2-93a1-86e14dbcfdd9,1785855744692/full/max/0/default.jpg?im=Crop%2Crect%3D%280%2C192%2C4499%2C2530%29%3BResize%3D%28620%29' alt='Congolese children read a poster' width='620' height='349' title='FILE PHOTO: Congolese children Ibrah Asimwe and Alex Uketi read an advocacy poster as aid agencies intensify efforts to contain a new Ebola outbreak involving the Bundibugyo strain outbreak, in Bunia, Ituri province, Democratic Republic of Congo, May 20,...
Read full article →
